Model for end‐stage liver disease (MELD) exception guidelines
Russell Wiesner, John R. Lake, Richard B. Freeman, Robert G. Gish – 22 November 2006
Model for end‐stage liver disease (MELD) exception for hereditary hemorrhagic telangiectasia
Guadalupe Garcia‐Tsao, Robert G. Gish, Jeffrey Punch – 22 November 2006
Model for end‐stage liver disease (MELD) exception for bacterial cholangitis
Gregory J. Gores, Robert G. Gish, Roshan Shrestha, Russell H. Wiesner – 22 November 2006
Model for end‐stage liver disease (MELD) exception for polycystic liver disease
Luis Arrazola, Dilip Moonka, Robert G. Gish, Gregory T. Everson – 22 November 2006
Model for end‐stage liver disease (MELD) exception for ascites
Scott W. Biggins, Steven Colquhoun, Robert G. Gish, Bruce A. Runyon – 22 November 2006
Model for end‐stage liver disease (MELD) exception for hepatopulmonary syndrome
Michael B. Fallon, David C. Mulligan, Robert G. Gish, Michael J. Krowka – 22 November 2006
Model for end‐stage liver disease (MELD) exception for portal hypertensive gastrointestinal bleeding
Patricia Sheiner, Robert G. Gish, Arun Sanyal – 22 November 2006
Model for end‐stage liver disease (MELD) exception guidelines: Results and recommendations from the MELD exception study group and conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standar
Richard B. Freeman, Robert G. Gish, Ann Harper, Gary L. Davis, John Vierling, Leslie Lieblein, Goran Klintmalm, Jamie Blazek, Robert Hunter, Jeffrey Punch – 22 November 2006
Model for end‐stage liver disease (MELD) exception for severe pruritus
W. Kenneth Washburn, Robert G. Gish – 22 November 2006
Model for end‐stage liver disease (MELD) exception for Budd‐Chiari syndrome
W. Kenneth Washburn, Robert G. Gish, Patrick S. Kamath – 22 November 2006